In subsequent clinical trials on patients without diabetes, weight loss results were replicated. Overweight and obese patients lost an average of 15-20% of their body weight (34 to 48 lbs.) over 72 weeks compared to a 3% loss in participants who were given a placebo injection.
Tirzepatide is the first drug of its kind to be approved by the FDA for weight management. It is meant for patients with a BMI of over 30, or patients who have a BMI over 27 with a weight-related health complication (sleep apnea, high cholesterol, etc.). Researchers have found it to produce more weight loss than semaglutide (Wegovy).
Tirzepatide also imitates the GIP (glucose-dependent insulinotropic polypeptide) hormone, which helps your body to develop more insulin and amplify your feeling of fullness.
It can take multiple weeks of Tirzepatide injections for the drug to affect your appetite. Consistent, weekly use produces the best results.
Ultimately, it is still up to you to consume fewer calories. However, since Tirzepatide can suppress your cravings, maintaining a healthier diet should be much easier. Patients who combine this injectable drug with a diet and exercise plan tend to achieve the best results.
Bariatrician Dr. Matt Wolins has helped many patients to reach their weight loss goals through a variety of methods, including medication. He understands that the best path to success is to combine a medication like Tirzepatide with a comprehensive nutrition and exercise plan.
Tirzepatide injections are performed by our team right here at our clinic, on a weekly basis. Medically supervised injections are the safest and most sanitary way to administer the dosages.
If your appetite and cravings have held you back from shedding excess weight, Tirzepatide may be just the tool you have been looking for to get on track. Please request a consultation online to learn more about Tirzepatide and other weight loss plans.